Your browser doesn't support javascript.
loading
Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain.
Hua, Yaping; Yuan, Xing; Shen, Yun-Heng; Wang, Jinxin; Azeem, Waqas; Yang, Shuo; Gade, Alexandra; Lellahi, Seyed Mohammad; Øyan, Anne Margrete; Ke, Xisong; Zhang, Wei-Dong; Kalland, Karl-Henning.
Afiliação
  • Hua Y; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Yuan X; Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, China.
  • Shen YH; Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, China.
  • Wang J; Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, China.
  • Azeem W; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Yang S; Department of Microbiology, Haukeland University Hospital, Helse Bergen, Bergen, Norway.
  • Gade A; Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
  • Lellahi SM; School of Pharmacy, East China University of Science and Technology, Shanghai, China.
  • Øyan AM; Centre for Molecular Medicine Norway, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Ke X; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Zhang WD; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Kalland KH; Department of Microbiology, Haukeland University Hospital, Helse Bergen, Bergen, Norway.
Front Pharmacol ; 13: 836724, 2022.
Article em En | MEDLINE | ID: mdl-35712699

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega País de publicação: Suíça